Lung cancer is the leading cause of cancer death worldwide,1, 2 but treatment outcomes have been improved with the development of targeted treatments for epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase, and c‐ros oncogene 1. This evidence concerns the gene EGFR and lung carcinoma.